IGF2BP2 and renal cell carcinoma: Therefore, in RCC cells, ZNF677 binds to the promoter of its target CDKN3 to regulate cellular activities, and is modified through an m6A‐dependent turnover mechanism by interacting with the m6A readers IGF2BP2 and YTHDF1.